R. Maisano
About
In The Last Decade
R. Maisano
46 papers receiving 522 citations
Peers
Comparison fields: 5 of 71
- Oncology 312
- Pulmonary and Respiratory Medicine 170
- Surgery 125
- Cancer Research 85
- Molecular Biology 76
Countries citing papers authored by R. Maisano
This map shows the geographic impact of R. Maisano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Maisano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Maisano more than expected).
Fields of papers citing papers by R. Maisano
This network shows the impact of papers produced by R. Maisano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Maisano. The network helps show where R. Maisano may publish in the future.
Co-authorship network of co-authors of R. Maisano
This figure shows the co-authorship network connecting the top 25 collaborators of R. Maisano. A scholar is included among the top collaborators of R. Maisano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Maisano. R. Maisano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 41 | |
| 2 | 1 | |
| 3 | 39 | |
| 4 | 28 | |
| 5 | 10 | |
| 6 | 2 | |
| 7 | 15 | |
| 8 | 21 | |
| 9 | Mitomycin C and capecitabine combination (MiXe) in heavily pretreated metastatic breast cancer patients. A dose-finding study. | 7 |
| 10 | 10 | |
| 11 | 10 | |
| 12 | 12 | |
| 13 | 14 | |
| 14 | 32 | |
| 15 | Complete regression of primary gastric MALT-lymphoma after double eradication Helicobacter pylori therapy: role and importance of endoscopic ultrasonography. | 10 |
| 16 | 39 | |
| 17 | Prognostic factors in ambulatory patients with inoperable locoregionally recurrent rectal cancer following curative surgery. | 6 |
| 18 | 6 | |
| 19 | 3 | |
| 20 | Efficacy of two oral dose regimens of granisetron. | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.